as on November 8, 2025 at 12:39 am IST
Day's Low
Day's High
1.23%
Downside
0.31%
Upside
52 Week's Low
52 Week's High
24.46%
Downside
23.69%
Upside
Check Atea Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$257.1M
EPS (TTM)
-1.635
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.64%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-145.0M
Revenue (TTM)
192.2M
Profit Margin
0.00%
Return On Equity TTM
-32.38%
Compare market cap, revenue, PE, and other key metrics of Atea Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $257.1M | -90.49% | NA | 0.00% | ||
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Atea Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atea Pharmaceuticals Inc investment value today
Current value as on today
₹99,583
Returns
Returns from Atea Pharmaceuticals Inc Stock
Dollar Returns*
₹5,107 (+5.11%)
Based on 9 analysts
11.11%
Buy
33.33%
Hold
55.56%
Sell
Based on 9 analysts, 55.56% of analysts recommend a 'SELL' rating for Atea Pharmaceuticals Inc. Average target price of $7.5
Get share price movements and forecasts by analysts on Atea Pharmaceuticals Inc.
What analysts predicted
56.67%UPSIDE
Target Price
$7.5
Current Price
$3.25
Analyzed by
9 Analysts
Target
$7.50
Atea Pharmaceuticals Inc target price $7.5, a slight upside of 56.67% compared to current price of $3.25. According to 9 analysts rating.
Search interest for Atea Pharmaceuticals Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:33% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 September
Tue, 04:30 PM
-Atea Pharmaceuticals to participate in Morgan Stanley Healthcare Conference on September 9, 2025.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, AVIR stock has moved up by 9.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 164.5%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 966.5%
| Organisation | Atea Pharmaceuticals Inc |
| Headquarters | 225 Franklin Street, Boston, MA, United States, 02110 |
| Industry | Health Technology |
| CEO | Dr. Jean-Pierre Sommadossi Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jonae R. Barnes | Senior Vice President of Investor Relations & Corporate Communications |
Mr. Adel Moussa Ph.D. | Executive Vice President of Chemistry |
Mr. Xiao-Jian Zhou Ph.D. | Executive Vice President of Early Stage Development |
Mr. Keith Pietropaolo | Executive VP of Clinical Sciences & Project Management |
Mr. Wayne Foster CPA | Executive VP of Finance & Chief Accounting Officer |
Dr. Jean-Pierre Sommadossi Ph.D. | Founder, Chairman, CEO & President |
Ms. Andrea J. Corcoran J.D. | CFO, Executive VP of Legal & Secretary |
Mr. John F. Vavricka | Chief Commercial Officer |
Dr. Janet M. J. Hammond M.D., Ph.D. | Chief Development Officer |
Dr. Maria Arantxa Horga M.D. | Chief Medical Officer |
Atea Pharmaceuticals Inc share price today is $3.25 as on . Atea Pharmaceuticals Inc share today touched a day high of $3.26 and a low of $3.21.
Atea Pharmaceuticals Inc share touched a 52 week high of $4.02 on and a 52 week low of $2.46 on . Atea Pharmaceuticals Inc stock price today i.e. is trending at $3.25,which is 19.15% down from its 52 week high and 32.38% up from its 52 week low.
Atea Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Atea Pharmaceuticals Inc (AVIR) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Atea Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atea Pharmaceuticals Inc share’s latest price of $3.25 as on November 8, 2025 at 12:39 am IST, you will get 3.0769 shares of Atea Pharmaceuticals Inc. Learn more about
fractional shares .
Atea Pharmaceuticals Inc stock has given -90.49% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?